The FAME two-year results, presented at TCT 2009, affirm the advantages of using FFR to guide multivessel intervention. FFR-guided PCI significantly improves patient outcomes and results in reduced procedural and healthcare costs, without prolonging the cath lab procedure, compared to angiography alone.

• reduced mortality and myocardial infarction at two years by 34%
  
• reduced MI at two years by 37%
  
• cost-saving and does not prolong procedure time
  
• decreased amount of contrast agent used